We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Levitronix Warned for Failing To Maintain Quality Standards
Levitronix Warned for Failing To Maintain Quality Standards
March 1, 2007
The FDA sent a warning letter to Levitronix for several cGMP violations, including failure to review complaints and set quality standards.